Effects of topiramate in patients with cerebellar tremor

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 27, Issue 6, 2003, Pages 1023-1027

  Sechi, GianPietro ^a   Agnetti, Virgilio ^a   Sulas, Franca M I ^a   Sau, GianFranco ^a   Corda, Davide ^a   Pitzolu, Maria G ^a   Rosati, Giulio ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Aggressiveness; Behavior; Cerebellar tremors; Cognition; Topiramate

Indexed keywords

CARBAMAZEPINE; TOPIRAMATE;

ADULT; AGED; AGGRESSION; ARTICLE; ASTHENIA; BEHAVIOR DISORDER; CEREBELLAR TREMOR; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRAWING; DROWSINESS; DRUG EFFECT; DRUG POTENCY; DRUG RESPONSE; DRUG SAFETY; DRUG SCREENING; EATING; EPISODICAL PARESTHESIA; FEMALE; GENERAL CONDITION IMPROVEMENT; HEAD TREMOR; HUMAN; KINETIC TREMOR; MALE; MONOTHERAPY; MOTOR DYSFUNCTION; PARESTHESIA; PATIENT; PATIENT ATTITUDE; POSTURAL TREMOR; PROSPECTIVE STUDY; SCORING SYSTEM; SEDATION; TASK PERFORMANCE; TREATMENT OUTCOME; TREMOR; WRITING;

EID: 0141517140     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(03)00170-2     Document Type: Article

References (31)

1. Alusi S.H., Worthington J., Gljckman S., Bain P.G. A study of tremor in multiple sclerosis. Brain. 124:2001;720-730.
2. Barrios Cerrejon M., Guardia Olmos J. Relation of the cerebellum with cognitive function: neuroanatomical, clinical and neuroimaging evidence. Rev. Neurol. 33:2001;582-591.
3. Biton V., Montouris G.D., Ritter F., Riviello J.J., Reife R., Lim P., Pledger G. A randomized, placebo-controlled study of topiramate in primary generalized tonic clonic seizures. Neurology. 52:1999;1330-1337.
4. Bozikas V.P., Petrikis P., Kourtis A., Youlis P., Karavatos A. Treatment of acute mania with topiramate in hospitalized patients. Prog. Neuro-psychopharmacol. Biol. Psychiatry. 26:2002;1203-1206.
5. Connor G.S. A double-blind placebo-controlled trial of topiramate treatment for essential tremor. Neurology. 59:2002;132-134.
6. De Lorenzo R.J., Sombati S., Coulter D.A. Effects of topiramate on sustained repetitive firing and spontaneous recurrent seizure discharges in cultured hippocampal neurons. Epilepsia. 41(Suppl. 1):2000;S40-S44.
7. Deuschl G., Bergman H. Pathophysiology of nonparkinsonian tremors. Mov. Disord. 17(Suppl. 3):2002;S41-S48.
8. Deuschl G., Bain P., Brin M. Consensus statement of the movement disorder society on tremor. Ad hoc scientific committee. Mov. Disord. 13(Suppl. 3):1998;s2-s23.
9. Elble R.J., Schieber M.H., Thach W.T. Jr. Activity of muscle spindles, motor cortex and cerebellar nuclei during action tremor. Brain Res. 323:1984;330-334.
10. Fonnum F., Storm-Matkisen J., Walberg F. Glutamate decarboxylase in inhibitory neurons. A study of the enzyme in Purkinje cell axons and boutons in the cat. Brain Res. 20:1970;259-275.
11. Fulton J.F., Liddel E.G.T., Riuch D.McK. Relation of the cerebrum to the cerebellum: I. Cerebellar tremor in the cat and its absence after removal of the cerebral hemispheres. Arch. Neurol. Psych. 28:1932;542-570.
12. Galvez-Jimenez N., Hargreave M. Topiramate and essential tremor. Ann. Neurol. 47:2000;837-838.
13. Genton P., Biraben A. Use of topiramate in clinical practice: Part 2. Multicentric retrospective evaluation of its safety. Rev. Neurol. (Paris). 156:2000;1120-1125.
14. Guy, W. (Ed.), 1976. ECDEU Assessment Manual for Psychopharmacology. DHEW Publication No. (ADM) 76-338. U.S. Department of Health, Education and Welfare, Bethesda, MD. Revised ed.
15. Heaney D., Shorvon S. Topiramate. Eadie M.J., Vajda F.J. Antiepileptic Drugs Pharmacology and Therapeutics. 1999;465-484 Springer, Berlin.
16. Huppertz H.J., Guiscke A., Schulze-Bonhage A. Cognitive impairments due to add-on therapy with topiramate. Nervenarzt. 72:2001;275-280.
17. Khan A., Faught E., Gilliam F., Kuzniecky R. Acute psychotic symptoms induced by topiramate. Seizure. 8:1999;235-237.
18. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 33:1983;1444-1452.
19. Marcotte D. Use of topiramate, a new antiepileptic as a mood stabilizer. J. Affect. Disord. 50:1998;245-251.
20. Narabayashi H. Tremor: its generating mechanism and treatment. Vinken P.J., Bruyn G.W., Klawans H.L. Extrapyramidal disorders. Handb. Clin. Neurol. 5(49):1986;597-607.
21. Pedroarena C.M., Schwarz C. Efficacy and short-term plasticity at GABAergic synapses between Purkinje and cerebellar nuclei neurons. J. Neurophysiol. 89:2003;704-715.
22. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis. Guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
23. Sachdeo R.C., Sachdeo S.K., Walker S.A., Kramer L.D., Nayak R.K., Doose D.R. Steady state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy. Epilepsia. 37:1996;774-780.
24. Schmahmann J.D., Sherman J.C. Cerebellar cognitive affective syndrome. Int. Rev. Neurobiol. 41:1997;433-440.
25. Schwarz C., Schmitz Y. Projection from the cerebellar lateral nucleus to precerebellar nuclei in the mossy fiber pathway is glutamatergic: a study combining anterograde tracing with immunogold labeling in the rat. J. Comp. Neurol. 381:1997;320-334.
26. Sechi G.P., Zuddas M., Piredda M., Agnetti V., Sau G., Piras M.L., Tanca S., Rosati G. Treatment of cerebellar tremors with carbamazepine: a controlled trial with long-term follow-up. Neurology. 39:1989;1113-1115.
27. Sechi G.P., Pirisi A., Agnetti V., Piredda M., Zuddas M., Tanca S., Piras M.L., Aiello I., Deserta F., Rosati G. Efficacy of carbamazepine on cerebellar tremors in patients with superior cerebellar artery syndrome. J. Neurol. 236:1989;461-463.
28. Sechi G.P., Casu A.R., Rosati G., Spanu A., Deserra F., Nuvoli S., Deiana G.A., Madeddu G. Cerebral and cerebellar diaschisis following carbamazepine therapy. Prog. Neuro-psychopharmacol. Biol. Psychiatry. 19:1995;889-901.
29. Trimble M.R., Rusch N., Betts T., Crawford P.M. Psychiatric symptoms after therapy with new antiepileptic drugs: psychopathological and seizure related variables. Seizure. 9:2000;249-254.
30. Troster A.I., Woods S.P., Fields J.A., Lyons K.E., Pahwa R., Higginson C.I., Koller W.C. Neuropsychological deficit in essential tremor: an expression of cerebello-thalamo-cortical pathophysiology? Eur. J. Neurol. 9:2002;143-151.
31. Wheeler S.D., Carrazana E.J. Topiramate-treated cluster headache. Neurology. 53:1999;274-276.